Table 1.
Characteristics of study groups.
| Parameter | Non-atherosclerotic | Atherosclerotic |
|---|---|---|
| Number (no.) of patients | 32 | 26 |
| Age (years) | 68.6 (7.6) | 71.0 (8.1) |
| Sex (Males/Females) | 18/14 | 20/6 |
| Cholesterol (mmol/L) | 4.78 (1.20) | 4.51 (1.03) |
| Triglycerides (mmol/L) | 1.56 (1.15) | 1.46 (0.71) |
| HDL (mmol/L) | 1.33 (0.42) | 1.33 (0.29) |
| LDL (mmol/L) | 2.74 (1.15) | 2.53 (0.88) |
| Height (cm) | 168 (9.5) | 166.7 (10.4) |
| Weight (kg) | 83.1 (12.8) | 84.7 (15.6) |
| BMI | 29.4 (5.0) | 30.5 (5.8) |
| Smoking (absolute no./from all patients) (%) | 5/32 (15.6) | 5/26 (19.2) |
| Inflammation, absolute no./from all assessed specimen (%) | 19/29 (65.5) | 13/23 (56.5) |
| Fibrosis, absolute no./from all assessed specimen (%) | 16/31 (51.6) | 11/26 (42.3) |
Patients with aortic stenosis were divided based on assessment of coronary perfusion into two groups: those with non-altered perfusion (non-atherosclerotic) and with decreased perfusion (atherosclerotic), for details see section materials and methods.
If not specified otherwise, the values represent the mean and standard deviation (in brackets).
Terms “Inflammation” and “Fibrosis” refers to valvular tissue.